DIRECT PP2A ACTIVATION FOR THE TREATMENT OF KRAS- AND EGFR-DRIVEN LUNG ADENOCARCINOMA
Rita Tohmé(Case Western Reserve University)
OhioLink ETD Center (Ohio Library and Information Network)
June 4, 2018
Cited by 1
Related Papers
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
|Journal of Clinical Investigation|2017|200